Bell Laboratories Inc. Overview
Bell Laboratories is a single-category specialist: it makes only rodent control products and describes itself as the world leader in rodent control technology. From one product in a Madison garage, it has built a portfolio spanning rodenticide baits, tamper-resistant bait stations, mechanical traps, glue boards, attractants and, most recently, sensor-enabled monitoring devices under the iQ name. It sells through distributors to pest management professionals and agricultural users in more than 50 countries on six continents, and manufactures mainly at a roughly 600,000 square foot campus in Windsor, Wisconsin. After 51 years of Stack family ownership it became a Berkshire Hathaway subsidiary in July 2025, with management and culture stated to be unchanged. Its strategic challenge is regulatory: anticoagulant rodenticides, the historic core, face tightening restrictions, which is pushing the company toward monitoring technology, traps and non-anticoagulant baits.
Company's own description. Bell describes itself as an exclusive manufacturer of rodent control products, producing rodenticides and other rodent control devices for the pest control and agricultural industries on six continents (PCT company profile, 2023). No annual report exists from which to quote.
Independent characterisation. Bell is a vertically focused formulator and manufacturer. It does not provide pest control services; it supplies the consumables and hardware that service companies use. The revenue model is product sales, overwhelmingly through specialist distributors rather than direct. A custom private-labelling service for bait stations (PMP, Jan 2026) adds a modest business-to-business customisation element. The iQ line introduces connected hardware with an app, but whether Bell charges recurring software or subscription fees is not publicly disclosed; trade coverage emphasises that the devices are affordable and integrated rather than describing a subscription.
Value chain position. Upstream are active-ingredient and resin suppliers; Bell formulates bait, moulds stations and traps, and assembles sensing devices. Downstream are distributors (for example Target Specialty Products lists Bell products), then pest management professionals (PMPs), agricultural producers and facility operators.
Customer types and end-markets. Professional structural pest control is the primary market, followed by agriculture and livestock production. Food processing, warehousing and other audited facilities are the natural users of the monitoring products. Revenue mix by customer type is not publicly disclosed.
Strategy
No annual report or investor day exists. Strategy is inferred from management statements in trade press.
The first theme is breadth: management repeatedly commits to offering the widest range of rodent control tools on the market. The second is smart monitoring: the iQ line is positioned as the growth engine, with the stated aim of reducing technician labour and giving data on when and where rodents are active. The third is regulatory adaptation: products such as Contrac California are designed for jurisdictions restricting conventional baits, and Lynch has publicly stressed preserving access to rodenticide tools on public health grounds. The fourth is capacity investment at Windsor. The fifth is commercial organisation, addressed by the March 2026 sales restructure, which management said was intended to support growth and customer service by relying on its people.
Medium-term financial targets, cost programme targets and formal ESG commitments are not publicly disclosed.
Products & Services
Pricing is set through distributors and is not disclosed by the company. Launch years are not publicly disclosed unless stated.
Rodenticide baits
Bait stations and trap covers (Protecta)
Traps, glue boards and attractants (Trapper, Provoke)
Bell Sensing Technologies (iQ)
The company claims iQ can save technicians up to 78 percent of labour time against standard devices (PMP, Jan 2026).
Product Portfolio
| Product | Description | Verification |
|---|---|---|
Rodent Cake | The founding product (1974) | PCT, Nov 2024 |
Contrac | Flagship anticoagulant bait line (bromadiolone) | Active ingredient: analyst recollection |
Contrac California | Variant developed for the California regulatory environment | — |
Contrac 24 | Recent Contrac line extension | — |
Cadet | Recently launched bait | — |
Final | Brodifacoum bait | Analyst recollection |
Fastrac | Bromethalin (non-anticoagulant) bait | Analyst recollection |
Ditrac | Diphacinone bait | Analyst recollection |
Terad3 | Cholecalciferol bait | Analyst recollection |
ZP | Zinc phosphide products for agricultural use | Analyst recollection |
Detex and Detex Soft Bait | Non-toxic monitoring bait; soft bait version recently launched | PCT 2026 |
| Product | Description | Source |
|---|---|---|
Protecta EVO Express | Bait station; also offered in an iQ version | PMP, Jan 2026 |
Protecta EVO Mouse | Triangular premium mouse station; holds two Blox or soft bait; single-lock EVO key | PCT |
RTU Mouse Bait Station | Long-standing triangular mouse station | PCT |
Protecta EVO Tunnel | Tamper-resistant cover for two T-Rex rat traps or mouse traps and glue trays; indoor/outdoor; with T-Rex meets New Zealand NAWAC welfare standards | PCT |
Protecta EVO Mouse Tunnel | Smaller cover, 13.75 x 3.25 x 3 inches, holds two Mouse iQ or Mini-Rex traps | PMP, 2026 |
Other EVO stations (Ambush, Circuit, Edge, Landscape), Protecta LP, Sidekick | Additional station formats | Analyst recollection |
Private-label stations | Custom branding service for customers | PMP, Jan 2026 |
| Product | Description | Source |
|---|---|---|
Trapper T-Rex | Rat snap trap | PMP, Jan 2026 |
Trapper Mini-Rex | Mouse snap trap | PCT |
Trapper 24/7 | Multiple-catch mouse trap | PMP, Jan 2026 |
Trapper Mouse glue trays; Trapper Max glue boards | Glue monitoring and capture | PCT |
Provoke | Rodent attractants | Analyst recollection |
| Product | Description | Source |
|---|---|---|
Express iQ | Sensor-enabled bait station | PMP, Jan 2026 |
T-Rex iQ | Sensor-enabled rat snap trap | PCT |
24/7 iQ | Sensor-enabled multiple-catch trap | PMP, Jan 2026 |
Mouse iQ | Sensor-enabled mouse trap | PMP, 2026 |
Financial Narrative
No financial statements have ever been published. Since 31 July 2025 Bell's results have been consolidated into Berkshire Hathaway, which does not break out a business of this size.
EPS, dividends per share, buybacks, margins, CAGR and all ratios (ROE, ROA, ROIC, leverage, coverage, cash conversion) are not applicable or not publicly disclosed.
Qualitative commentary. Three indirect signals are available. The company sustained 51 years of single-family ownership without outside capital, which implies self-funded growth. It planned a technical manufacturing addition to an already large plant in 2024, which implies capacity demand. And Berkshire Hathaway, whose stated acquisition criteria emphasise consistent earnings and good returns on equity, chose to buy it. None of these is a substitute for figures.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansAnalyst Conclusions
Management provides no guidance and there is no consensus.
Bull case. First, ownership permanence removes succession and financing uncertainty. Second, labour shortages in pest control favour connected monitoring, where Bell has an installed distribution base to sell through. Third, regulatory change may favour the incumbent with the resources to reformulate and re-register, squeezing smaller rivals.
Bear case. First, the profit pool has historically sat in anticoagulant baits, and restriction could shrink it faster than monitoring grows. Second, sensing is a software-led contest in which Bell is not obviously advantaged. Third, with no disclosure, outside parties cannot detect deterioration early.
Monitorables for the next 12 months. EPA rodenticide decisions and further state legislation; progress on the Windsor manufacturing addition; further iQ product extensions; any senior appointments following the March 2026 restructure; any mention of Bell in Berkshire Hathaway's annual report or shareholder letter; any bolt-on acquisition.
Analyst verdict. Bell Laboratories is a well-regarded niche industrial business that is easy to describe and impossible to quantify from public sources. What can be said with confidence is qualitative. The company has spent half a century doing one thing, has built a product range that covers every method a professional uses against rodents, sells on six continents from a single large Wisconsin campus, and was judged attractive enough for Berkshire Hathaway to buy outright in July 2025 while leaving management in place. Its direction of travel is also clear: toward sensor-enabled monitoring, toward baits engineered for restrictive jurisdictions, and toward trap systems that meet welfare standards. The principal uncertainty is regulatory, and it is material, because the traditional chemistry is under sustained pressure in the company's most important markets. For a counterparty, supplier or competitor, Bell should be treated as a stable, well-backed and strategically coherent operator whose financial profile must be established through primary research: distributor interviews, customer checks, import and export data, and pesticide registration records. For an investor, there is no direct way to own it. Any work that requires revenue, margin or share figures should budget for primary research rather than relying on aggregator estimates, which conflict even on headcount.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Notes | Source |
|---|---|---|---|
Steve Levy | President and CEO | PMP Hall of Fame, class of 2022 | PMP |
Patrick Lynch, ACE | Executive Vice President and Chief Commercial Officer | Previously CCO and President of Bell Sensing; earlier SVP Global Sales; about 20 years at Bell; all directors and Bell Sensing staff report to him | PMP Mar 2026; PCT |
Scott Smith | Director of Sales, West Region | Named in March 2026 restructure | PMP |
Seth Keller | Sales Analytics Manager, Bell Sensing Technologies | Named in March 2026 restructure | PMP |
Brian Hensel | Senior Technical Representative, Bell Sensing Technologies and Canada | Named in March 2026 restructure | PMP |
Competitive Landscape
Key Competitors
| Competitor | Area of overlap | Ownership |
|---|---|---|
Liphatech | Rodenticide baits | Private (De Sangosse group) |
BASF | Rodenticides | Public |
Syngenta | Rodenticides | State-owned (Sinochem) |
Envu | Rodenticides | Private (Cinven) |
Neogen | Rodenticides | Public |
UPL | Rodenticides | Public |
Sumitomo Chemical | Rodenticides | Public |
PelGar International | Rodenticides | Private |
Woodstream (Victor) | Traps | Private |
Xignal | Sensor-enabled traps | Private |
Apex Bait Technologies | Baits | Private |
SenesTech | Fertility control baits | Public |



